The filing

Zydus and Formycon: FYB206 Becomes First Publicly Announced Keytruda Biosimilar Accepted for Review by UDFDA.

Company

Zydus Lifesciences Ltd · BSE 532321

Filed

13 October 2026, 09:50 IST

BSE category

Company Update / Press Release / Media Release

Tag

Press Release · selected

Source

Open the filing on BSE →

Why it led

• Large cap · NIFTY 500

Selected by the ranker from 9 filings that day. Each line above is a component of that score, not a comment on the filing.

How often this tag appears

2,219 of 89,756 filings in the published window carry Press Release · 2.47%

Around it

Most recent filings from Zydus Lifesciences Ltd

• Press Release / Media Release Press Release12 October 2026 · 18:00 IST
• Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 Compliance Certificate6 October 2026 · 17:09 IST
• Press Release / Media Release Press Release5 October 2026 · 20:44 IST